Sign inGet started

Springhorn Jeremy P.

Insider CIK 1717852 · SYRS Chief Business Officer · QURE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
QURE uniQure N.V. S Sale2026-06-112026-06-121,993$27.06 $53.9K43,251SEC↗
QURE uniQure N.V. A Award deriv2026-06-102026-06-1213,980— $013,980SEC↗
QURE uniQure N.V. A Award2026-06-102026-06-127,550— $045,244SEC↗
QURE uniQure N.V. S Sale2025-06-202025-06-242,112$14.45 $30.5K37,694SEC↗
QURE uniQure N.V. A Award deriv2025-06-112025-06-1315,630— $015,630SEC↗
QURE uniQure N.V. A Award2025-06-112025-06-137,970— $039,806SEC↗
QURE uniQure N.V. A Award deriv2024-06-192024-06-2115,840— $015,840SEC↗
QURE uniQure N.V. A Award2024-06-192024-06-218,080— $031,836SEC↗
QURE uniQure N.V. S Sale2024-06-132024-06-172,231$5.12 $11.4K23,756SEC↗
QURE uniQure N.V. S Sale2023-06-162023-06-202,286$18.88 $43.2K25,987SEC↗
QURE uniQure N.V. A Award deriv2023-06-132023-06-2017,060— $017,060SEC↗
QURE uniQure N.V. A Award2023-06-132023-06-208,700— $028,273SEC↗
QURE uniQure N.V. S Sale2023-02-272023-03-01384$20.41 $7.8K19,573SEC↗
QURE uniQure N.V. A Award deriv2022-06-152022-06-1717,810— $017,810SEC↗
QURE uniQure N.V. A Award2022-06-152022-06-179,080— $019,957SEC↗
QURE uniQure N.V. S Sale2022-02-282022-03-02602$16.70 $10.1K10,877SEC↗
QURE uniQure N.V. A Award deriv2022-02-242022-02-282,645— $02,645SEC↗
QURE uniQure N.V. A Award2022-02-242022-02-281,534— $011,479SEC↗
QURE uniQure N.V. S Sale2021-03-022021-03-04505$37.50 $18.9K9,945SEC↗
QURE uniQure N.V. A Award deriv2021-02-252021-03-014,107— $04,107SEC↗
QURE uniQure N.V. A Award2021-02-252021-03-012,382— $010,450SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2021-02-172021-02-1994,000— $094,000SEC↗
QURE uniQure N.V. A Award deriv2020-02-272020-03-023,620— $03,620SEC↗
QURE uniQure N.V. A Award2020-02-272020-03-022,063— $08,068SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2020-02-132020-02-1494,000— $094,000SEC↗
QURE uniQure N.V. S Sale2020-01-282020-01-304$60.94 $2446,808SEC↗
QURE uniQure N.V. S Sale2020-01-282020-01-30803$62.20 $49.9K6,005SEC↗
SYRS Syros Pharmaceuticals, Inc P Buy2019-11-122019-11-1210,121$4.97 $50.3K35,000SEC↗
SYRS Syros Pharmaceuticals, Inc P Buy2019-11-112019-11-129,879$4.99 $49.3K24,879SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2019-02-122019-02-1475,000— $075,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award2019-02-122019-02-1487,000— $0102,000SEC↗
QURE uniQure N.V. S Sale2019-01-282019-01-301,210$31.32 $37.9K6,812SEC↗
QURE uniQure N.V. A Award deriv2019-01-252019-01-295,295— $05,295SEC↗
QURE uniQure N.V. A Award2019-01-252019-01-293,230— $08,022SEC↗
QURE uniQure N.V. A Award deriv2018-01-262018-01-306,390— $06,390SEC↗
QURE uniQure N.V. A Award2018-01-262018-01-304,792— $04,792SEC↗
SYRS Syros Pharmaceuticals, Inc P Buy2017-12-152017-12-1515,000$9.08 $136.2K15,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2017-11-132017-11-1450,000— $050,000SEC↗
SYRS Syros Pharmaceuticals, Inc A Award deriv2017-11-132017-11-14150,000— $0150,000SEC↗
QURE uniQure N.V. A Award deriv2017-09-202017-09-2610,000— $010,000SEC↗